Oral cancer screening for early mouth changes
Part of Cancer, Mouth & dental, Skin clinical trials.
This trial tests an oral (mouth) screening approach to catch early, possibly cancer-pre-cursor changes. It may help you find warning spots sooner if you have specific mouth lesions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with leukoplakia, erythroplakia, or proliferative verrucous leukoplakia
- You can read and understand the study information in Swedish
- You are not currently receiving chemotherapy
- You are not currently receiving radiotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies two ways to check whether early oral cavity cancer has spread to nearby neck lymph nodes. It compares sentinel node biopsy versus limited elective neck dissection to see which approach is more useful for people with node-negative tongue or inner-cheek cancers.
This trial aims to improve oral health in people being treated for head and neck cancer. If you are receiving radiation therapy, this study may help manage side effects and keep your mouth healthier.
This study looks at tissue and blood samples from people with mouth conditions that could become cancer or are already cancer. It aims to learn more about these conditions to improve diagnosis and treatment.
This study compares two non-invasive methods to detect precancerous sores in the mouth. It aims to find a simpler way to catch early changes before they become cancer.
This study checks how well routine mouth exams can find early signs of oral cancer. It is for adults who do not already have a condition called OPMD (a mouth problem that can lead to cancer) and are not being treated for it.
This study looks at oral leukoplakia (persistent white patches in the mouth) to better predict which ones may develop into cancer. It uses a test based on specific immune and cancer-related markers to help estimate each person’s risk.
Hear when a new Mouth Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.